53
Views
2
CrossRef citations to date
0
Altmetric
Original Research

ABCB1 C3435T polymorphism is associated with leukemia susceptibility: evidence from a meta-analysis

, , , &
Pages 1009-1015 | Published online: 05 May 2015

References

  • SiegelRLMillerKDJemalACancer statistics, 2015CA Cancer J Clin201565152925559415
  • InabaHGreavesMMullighanCGAcute lymphoblastic leukaemiaLancet201338198811943195523523389
  • FinchSCRadiation-induced leukemia: lessons from historyBest Pract Res Clin Haematol200720110911817336261
  • BjörkJJohanssonBBrobergKAlbinMSmoking as a risk factor for myelodysplastic syndromes and acute myeloid leukemia and its relation to cytogenetic findings: a case-control studyLeuk Res200933678879119019430
  • LichtmanMAObesity and the risk for a hematological malignancy: leukemia, lymphoma, or myelomaOncologist201015101083110120930095
  • MullighanCGGenetic variation and the risk of acute lymphoblastic leukemiaLeuk Res201034101269127020538337
  • SherborneALHoskingFJPrasadRBVariation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia riskNat Genet201042649249420453839
  • WangYChenJLiJAssociation of three polymorphisms in ARID5B, IKZF1 and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese populationGene2013524220320723608171
  • SpeedyHEDi BernardoMCSavaGPA genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemiaNat Genet2014461566024292274
  • SchinkelAHThe physiological function of drug-transporting P-glycoproteinsSemin Cancer Biol1997831611709441946
  • SunJHeZGChengGWangSJHaoXHZouMJMultidrug resistance P-glycoprotein: crucial significance in drug disposition and interactionMed Sci Monit2004101RA5RA1414704647
  • HodgesLMMarkovaSMChinnLWVery important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)Pharmacogenet Genomics201121315216120216335
  • BreierABarancíkMSulováZUhrikBP-glycoprotein – implications of metabolism of neoplastic cells and cancer therapyCurr Cancer Drug Targets20055645746816178819
  • HoffmeyerSBurkOvon RichterOFunctional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivoProc Natl Acad Sci U S A20009773473347810716719
  • KurataYIeiriIKimuraMRole of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoproteinClin Pharmacol Ther200272220921912189368
  • LambaJStromSVenkataramananRMDR1 genotype is associated with hepatic cytochrome P450 3A4 basal and induction phenotypeClin Pharmacol Ther200679432533816580901
  • MarzoliniCPausEBuclinTKimRBPolymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevanceClin Pharmacol Ther2004751133314749689
  • Brambila-TapiaAJMDR1 (ABCB1) polymorphisms: functional effects and clinical implicationsRev Invest Clin201365544545424687344
  • BaldisseraVDde MattosAACoralGPEvaluation of the C3435T polymorphism in the MDR1 gene in patients with hepatocellular carcinomaAnn Hepatol201211689990623109454
  • WangZWangTBianJAssociation between MDR1 C3435T polymorphism and risk of breast cancerGene20135321949924070710
  • KimHNKimNYYuLPolymorphisms in DNA repair genes and MDR1 and the risk for non-Hodgkin lymphomaInt J Mol Sci20141546703671624756092
  • JamroziakKMłynarskiWBalcerczakEFunctional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemiaEur J Haematol200472531432115059065
  • JamroziakKBalcerczakECebulaBJanusAMirowskiMRobakTNo influence of 3435C>T ABCB1 (MDR1) gene polymorphism on risk of adult acute myeloid leukemia and P-glycoprotein expression in blast cellsTher Drug Monit200628570771117038891
  • JamroziakKBalcerczakESmolewskiPMDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemiaPharmacol Rep200658572072817085864
  • HattoriHSuminoeAWadaMRegulatory polymorphisms of multidrug resistance 1 (MDR1) gene are associated with the development of childhood acute lymphoblastic leukemiaLeuk Res200731121633164017568669
  • UrayamaKYWienckeJKBufflerPAChokkalingamAPMetayerCWiemelsJLMDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemiaCancer Epidemiol Biomarkers Prev20071661172117717548681
  • Leal-UgarteEGutiérrez-AnguloMMacías-GómezNMMDR1 C3435T polymorphism in Mexican children with acute lymphoblastic leukemia and in healthy individualsHum Biol200880444945519317599
  • LiuRRThe role of multidrug resistance gene 1 polymorphism to prognosis of adult acute lymphoblastic leukemia patientsCentral South University20085148
  • SemseiAFErdélyiDJUngváriIAssociation of some rare haplotypes and genotype combinations in the MDR1 gene with childhood acute lymphoblastic leukaemiaLeuk Res20083281214122018243305
  • RochaVPorcherRFernandesJFAssociation of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemiaLeukemia200923354555619005482
  • RaoDNAnuradhaCVishnupriyaSAssociation of an MDR1 gene (C3435T) polymorphism with acute leukemia in IndiaAsian Pac J Cancer Prev20101141063106621133625
  • PennaGAllegraAAlonciAMDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosisMed Oncol20112841549155420496015
  • Bektaş-KayhanKKüçükhüseyinÖKaragözGIs the MDR1 C3435T polymorphism responsible for oral mucositis in children with acute lymphoblastic leukemia?Asian Pac J Cancer Prev201213105251525523244145
  • LüHDuZZWangWRelationship between genetic polymorphism of multidrug resistance 1 gene and the risk of childhood acute lymphocytic leukemiaZhonghua Er Ke Za Zhi2012509692696 Chinese23158821
  • GréenHFalkIJLotfiKAssociation of ABCB1 polymorphisms with survival and in vitro cytotoxicity in de novo acute myeloid leukemia with normal karyotypePharmacogenomics J201212211111820938465
  • SinghOChanJYLinKHengCCChowbayBSLC22A1-ABCB1 haplotype profiles predict imatinib pharmacokinetics in Asian patients with chronic myeloid leukemiaPLoS One2012712e5177123272163
  • VivonaDBuenoCTLimaLTABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinibBlood Cells Mol Dis201248213213622134106
  • ZhaiXWangHZhuXGene polymorphisms of ABC transporters are associated with clinical outcomes in children with acute lymphoblastic leukemiaArch Med Sci20128465967123056078
  • SongPLambaJKZhangLG2677T and C3435T genotype and haplotype are associated with hepatic ABCB1 (MDR1) expressionJ Clin Pharmacol200646337337916490813
  • Kimchi-SarfatyCOhJMKimIWA “silent” polymorphism in the MDR1 gene changes substrate specificityScience2007315581152552817185560
  • TeraoTHisanagaESaiYTamaiITsujiAActive secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrierJ Pharm Pharmacol19964810108310898953513
  • TanigawaraYRole of P-glycoprotein in drug dispositionTher Drug Monit200022113714010688277
  • ElliottJIRaguzSHigginsCFMultidrug transporter activity in lymphocytesBr J Pharmacol2004143789990715492020
  • PawlikABaskiewicz-MasiukMMachalinskiBKurzawskiMGawronska-SzklarzBInvolvement of C3435T and G2677T multidrug resistance gene polymorphisms in release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasoneEur J Pharmacol20055281–3273616321374
  • QianXCaoSYangGVariant genotypes of MDR1 C3435T increase the risk of leukemia: evidence from 10 case-control studiesLeuk Lymphoma20125361183118722088099